Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
3.070
+0.020 (0.66%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Evaxion Employees
Evaxion had 46 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Evaxion the 35,278th largest employer in the world and 4,746th in the United States.
Employees
46
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$162,848
Profits / Employee
-$188,152
Market Cap
25.60M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 46 | 0 | - |
| Dec 31, 2024 | 46 | -3 | -6.12% |
| Dec 31, 2023 | 49 | -14 | -22.22% |
| Dec 31, 2022 | 63 | 2 | 3.28% |
| Dec 31, 2021 | 61 | 26 | 74.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IGC Pharma | 70 |
| Seres Therapeutics | 66 |
| aTyr Pharma | 60 |
| BeyondSpring | 44 |
| Kyntra Bio | 34 |
| ABVC BioPharma | 19 |
| Quantum BioPharma | 17 |
| Atossa Therapeutics | 16 |
EVAX News
- 8 days ago - Evaxion Biotech to present new immune data on EVX-01 at SITC 2026 - TheFly
- 8 days ago - Evaxion will present new immune data for personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting - GlobeNewsWire
- 26 days ago - Evaxion applies its AI-Immunology™ platform in autoimmune diseases - GlobeNewsWire
- 7 weeks ago - Evaxion Earnings Call Transcript: Q2 2026 - Transcripts
- 7 weeks ago - Evaxion Earnings release: Q2 2026 - Filings
- 7 weeks ago - Evaxion Slides: Q2 2026 - Filings
- 7 weeks ago - Evaxion announces business update and second quarter 2026 financial results - GlobeNewsWire
- 7 weeks ago - Evaxion expands and refocuses R&D pipeline with EVX-05, an AI-designed off-the-shelf brain cancer vaccine program - GlobeNewsWire